Protein co-expression networks identified from HOT lesions of ER+HER2–Ki-67high luminal breast carcinomas
Abstract Patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative/Ki-67-high (ER+HER2–Ki-67high) luminal breast cancer have a worse prognosis and do not respond to hormonal treatment and chemotherapy. This study sought to identify disease-related protein networks si...
Guardado en:
Autores principales: | Kimito Yamada, Toshihide Nishimura, Midori Wakiya, Eiichi Satoh, Tetsuya Fukuda, Keigo Amaya, Yasuhiko Bando, Hiroshi Hirano, Takashi Ishikawa |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3846f737546a4c368ddfcb4d4d714ceb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantum dot-based immunofluorescent imaging of Ki67 and identification of prognostic value in HER2-positive (non-luminal) breast cancer
por: Sun JZ, et al.
Publicado: (2014) -
Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients
por: Junmei Hao, et al.
Publicado: (2021) -
Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
por: Ceren Boyaci, et al.
Publicado: (2021) -
KI67 AND P53 PROTEINS IN ODONTOGENIC KERATOCYST
por: S Seifi, et al.
Publicado: (2008) -
Expression of Endothelin-1 and Ki-67 in Normotensive and Severe Preeclamptic Placentas
por: Ekinci,Aysun, et al.
Publicado: (2018)